ResearcherTeikyo UniversityActive in the last 2 years
Miho Akimoto
Matched on ORCID iD 0000-0003-1774-2257; OpenAlex author ID A5041181447. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic cancer cells. Co-author DOI 10.1002/2211-5463.70099↗
- Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice. First author DOI 10.1038/s41598-021-82617-2↗
- Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model. First author DOI 10.1371/journal.pone.0232230↗
- Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis. Co-author DOI 10.1038/s41419-018-0851-z↗
- HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Co-author DOI 10.18632/oncotarget.17157↗
- Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death. Co-author DOI 10.1371/journal.pone.0126605↗
- Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells. First author DOI 10.1007/s10585-012-9519-8↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keizo Takenaga · 5 shared papers, 2013–2025 · strength 0.74
- Paper Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic ca… DOI 10.1002/2211-5463.70099↗
- Paper Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice. DOI 10.1038/s41598-021-82617-2↗
- Paper Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-… DOI 10.1038/s41419-018-0851-z↗
- Hiroki Nagase · 2 shared papers, 2020–2021 · strength 0.35
- Paper Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice. DOI 10.1038/s41598-021-82617-2↗
- Paper Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer m… DOI 10.1371/journal.pone.0232230↗
- Keizo Takenaga · 2 shared papers, 2015–2020 · strength 0.23
- Paper Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer m… DOI 10.1371/journal.pone.0232230↗
- Paper Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Aut… DOI 10.1371/journal.pone.0126605↗
- Yoshitsugu Tajima · 2 shared papers, 2013–2018 · strength 0.15
- Paper Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-… DOI 10.1038/s41419-018-0851-z↗
- Paper Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and… DOI 10.1007/s10585-012-9519-8↗
- Yasunari Kawabata · 1 shared paper, 2018 · strength 0.11
- Nanae Harashima · 1 shared paper, 2017 · strength 0.10
- Mamoru Harada · 1 shared paper, 2017 · strength 0.10
- Yoshihide Shimojo · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.